FDMT - 4D Molecular Therapeutics Inc

https://www.4dmoleculartherapeutics.com

Hold Momentum: Bearish

Recent News

Jim Cramer: AppLovin Calls For Prudence, This Health Care Stock Is 'Pure Spec' - AppLovin ( NASDAQ:APP ) , Ameris ( NYSE:ABCB )

Benzinga • 1 week, 5 days ago • score: 0.10

"Let's take a little off the table just to be prudent," Cramer on AppLovin. SiTime is just a "very good" company, says Cramer. Post-Labor Day Trading Could Trigger Major Market Moves. Here's How to Trade It On CNBC's "Mad Money Lightning Round," Jim Cramer doesn't recommend buying more AppLovin ...

Bullish

4D Molecular Therapeutics, Inc. ( FDMT ) Reports Q2 Loss, Misses Revenue Estimates

Zacks Commentary • 1 month ago • score: 0.16

4D Molecular Therapeutics (FDMT) delivered earnings and revenue surprises of -11.36% and -98.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California.

52W High

$17.41

52W Low

$2.24

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

2.85

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-3.55

EV/Revenue (<3 favorable)

2102.39

P/S (TTM) (<3 favorable)

10288.70

P/B (<3 favorable)

0.81

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

3.85%

Institutions (25–75% balanced)

87.86%

Shares Outstanding

46,702,500

Float

35,704,500

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

33,000

Gross Profit (TTM)

-170,188,992

EPS (TTM)

-3.53

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-3963.73%

ROE (TTM) (>15% strong)

-0.39%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

2.00

Momentum

Bearish momentum

Value

0.3669

0.3973

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025